|
VPS13C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.942030E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.014200E-01 |
| Normal-vs-Stage2 |
1.590360E-01 |
| Normal-vs-Stage3 |
2.868400E-01 |
| Normal-vs-Stage4 |
1.860430E-01 |
| Stage1-vs-Stage2 |
3.870400E-01 |
| Stage1-vs-Stage3 |
8.003000E-01 |
| Stage1-vs-Stage4 |
5.621400E-01 |
| Stage2-vs-Stage3 |
5.578400E-01 |
| Stage2-vs-Stage4 |
7.978800E-01 |
| Stage3-vs-Stage4 |
7.349600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.480400E-01 |
| Normal-vs-AfricanAmerican |
8.225600E-01 |
| Normal-vs-Asian |
4.815600E-01 |
| Caucasian-vs-AfricanAmerican |
3.678000E-01 |
| Caucasian-vs-Asian |
9.028400E-01 |
| AfricanAmerican-vs-Asian |
4.721600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.216200E-02 |
| Normal-vs-Female |
3.934200E-01 |
| Male-vs-Female |
7.565600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.521600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.317570E-01 |
| Normal-vs-Age(61-80Yrs) |
2.047200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.961590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.644600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.261600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.860600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.168400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.063400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.364400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.927200E-01 |
| Classical-VS-Follicular |
2.444700E-04 |
| Classical-VS-Other |
1.173610E-01 |
| Classical-VS-Normal |
7.858600E-01 |
| Tall-VS-Follicular |
2.097100E-03 |
| Tall-VS-Other |
6.222400E-02 |
| Tall-VS-Normal |
5.484200E-01 |
| Follicular-VS-Other |
6.868400E-01 |
| Follicular-VS-Normal |
1.975540E-03 |
| Other-VS-Normal |
5.472100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.520000E-02 |
| Normal-vs-N1 |
2.820400E-01 |
| N0-vs-N1 |
5.520200E-01 |
|
|
